Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Birth outcomes in Aboriginal mother-infant pairs from the Northern Territory, Australia, who received 23-valent polysaccharide pneumococcal vaccination during pregnancy, 2006-2011: The PneuMum randomised controlled trial.

McHugh L, Binks M, Ware RS, Snelling T, Nelson S, Nelson J, Dunbar M, Mulholland EK, Andrews RM.

Aust N Z J Obstet Gynaecol. 2019 Jun 14. doi: 10.1111/ajo.13002. [Epub ahead of print]

PMID:
31198999
2.

Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine.

von Mollendorf C, Dunne EM, La Vincente S, Ulziibayar M, Suuri B, Luvsantseren D, Narangerel D, Ortika BD, Pell CL, Nation ML, Alamrousi A, Hinds J, Demberelsuren S, Nguyen C, Mungun T, Mulholland EK, Satzke C.

Vaccine. 2019 Jun 4. pii: S0264-410X(19)30715-7. doi: 10.1016/j.vaccine.2019.05.078. [Epub ahead of print]

3.

Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice.

Manning J, Dunne EM, Wang N, Pedersen JS, Ogier JM, Burt RA, Mulholland EK, Robins-Browne RM, Malley R, Wijburg OL, Satzke C.

Vaccine. 2019 Jun 6;37(26):3495-3504. doi: 10.1016/j.vaccine.2019.03.013. Epub 2019 May 15.

4.

Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.

Temple B, Toan NT, Dai VTT, Bright K, Licciardi PV, Marimla RA, Nguyen CD, Uyen DY, Balloch A, Huu TN, Mulholland EK.

Lancet Infect Dis. 2019 May;19(5):497-509. doi: 10.1016/S1473-3099(18)30734-5. Epub 2019 Apr 8.

5.

Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned.

La Vincente SF, von Mollendorf C, Ulziibayar M, Satzke C, Dashtseren L, Fox KK, Dunne EM, Nguyen CD, de Campo J, de Campo M, Thomson H, Surenkhand G, Demberelsuren S, Bujinlkham S, Do LAH, Narangerel D, Cherian T, Mungun T, Mulholland EK.

BMC Public Health. 2019 Mar 21;19(1):333. doi: 10.1186/s12889-019-6639-y.

6.

Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.

Satzke C, Dunne EM, Choummanivong M, Ortika BD, Neal EFG, Pell CL, Nation ML, Fox KK, Nguyen CD, Gould KA, Hinds J, Chanthongthip A, Xeuatvongsa A, Mulholland EK, Sychareun V, Russell FM.

Vaccine. 2019 Jan 7;37(2):296-305. doi: 10.1016/j.vaccine.2018.10.077. Epub 2018 Nov 28.

7.

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys.

Dunne EM, Satzke C, Ratu FT, Neal EFG, Boelsen LK, Matanitobua S, Pell CL, Nation ML, Ortika BD, Reyburn R, Jenkins K, Nguyen C, Gould K, Hinds J, Tikoduadua L, Kado J, Rafai E, Kama M, Mulholland EK, Russell FM.

Lancet Glob Health. 2018 Dec;6(12):e1375-e1385. doi: 10.1016/S2214-109X(18)30383-8.

8.

Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene.

Manna S, Dunne EM, Ortika BD, Pell CL, Kama M, Russell FM, Mungun T, Mulholland EK, Hinds J, Satzke C.

PLoS One. 2018 Nov 5;13(11):e0206622. doi: 10.1371/journal.pone.0206622. eCollection 2018.

9.

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine.

Toh ZQ, Cheow KWB, Russell FM, Hoe E, Reyburn R, Fong J, Tuivaga E, Ratu FT, Nguyen CD, Matanitobua S, Reitsma A, Tabrizi SN, Garland SM, Mulholland EK, Licciardi PV.

Open Forum Infect Dis. 2018 Jun 20;5(7):ofy147. doi: 10.1093/ofid/ofy147. eCollection 2018 Jul.

10.

The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind, randomised controlled trial.

O'Grady KF, Chang AB, Cripps A, Mulholland EK, Smith-Vaughan H, Wood N, Danchin M, Thornton R, Wilson A, Torzillo PJ, Morris PM, Richmond P, Rablin S, Arnold D, Connor A, Goyal V, Stoney T, Perrett K, Grimwood K.

Hum Vaccin Immunother. 2018 Jun 26:1-12. doi: 10.1080/21645515.2018.1488562. [Epub ahead of print]

PMID:
29944440
11.

Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial.

Temple B, Toan NT, Uyen DY, Balloch A, Bright K, Cheung YB, Licciardi P, Nguyen CD, Phuong NTM, Satzke C, Smith-Vaughan H, Vu TQH, Huu TN, Mulholland EK.

BMJ Open. 2018 Jun 8;8(6):e019795. doi: 10.1136/bmjopen-2017-019795.

12.

Epidemiology and risk factors for typhoid fever in Central Division, Fiji, 2014-2017: A case-control study.

Prasad N, Jenkins AP, Naucukidi L, Rosa V, Sahu-Khan A, Kama M, Jenkins KM, Jenney AWJ, Jack SJ, Saha D, Horwitz P, Jupiter SD, Strugnell RA, Mulholland EK, Crump JA.

PLoS Negl Trop Dis. 2018 Jun 8;12(6):e0006571. doi: 10.1371/journal.pntd.0006571. eCollection 2018 Jun.

13.

Predicting the impact of pneumococcal conjugate vaccine programme options in Vietnam.

Le Polain De Waroux O, Edmunds WJ, Takahashi K, Ariyoshi K, Mulholland EK, Goldblatt D, Choi YH, Anh DD, Yoshida LM, Flasche S.

Hum Vaccin Immunother. 2018;14(8):1939-1947. doi: 10.1080/21645515.2018.1467201. Epub 2018 Jun 8.

14.

Interlaboratory Comparison of the Pneumococcal Multiplex Opsonophagocytic Assays and Their Level of Agreement for Determination of Antibody Function in Pediatric Sera.

Balloch A, Roalfe L, Ekstrom N, Nguyen CD, Spry L, Marimla RA, Licciardi PV, Goldblatt D, Mulholland EK.

mSphere. 2018 Apr 25;3(2). pii: e00070-18. doi: 10.1128/mSphere.00070-18. Print 2018 Apr 25.

15.

Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study.

Dunne EM, Murad C, Sudigdoadi S, Fadlyana E, Tarigan R, Indriyani SAK, Pell CL, Watts E, Satzke C, Hinds J, Dewi NE, Yani FF, Rusmil K, Mulholland EK, Kartasasmita C.

PLoS One. 2018 Apr 12;13(4):e0195098. doi: 10.1371/journal.pone.0195098. eCollection 2018.

16.

Cervical Cancer Prevention Through HPV Vaccination in Low- and Middle-Income Countries in Asia

Toh ZQ, Licciardi PV, Russell FM, Garland SM, Batmunkh T, Mulholland EK.

Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2339-2343.

17.

A cross-sectional seroepidemiological survey of typhoid fever in Fiji.

Watson CH, Baker S, Lau CL, Rawalai K, Taufa M, Coriakula J, Thieu NTV, Van TT, Ngoc DTT, Hens N, Lowry JH, de Alwis R, Cano J, Jenkins K, Mulholland EK, Nilles EJ, Kama M, Edmunds WJ.

PLoS Negl Trop Dis. 2017 Jul 20;11(7):e0005786. doi: 10.1371/journal.pntd.0005786. eCollection 2017 Jul.

18.

Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study.

Toh ZQ, Russell FM, Reyburn R, Fong J, Tuivaga E, Ratu T, Nguyen CD, Devi R, Kama M, Matanitobua S, Tabrizi SN, Garland SM, Sinha R, Frazer I, Tikoduadua L, Kado J, Rafai E, Mulholland EK, Licciardi PV.

Clin Infect Dis. 2017 Apr 1;64(7):852-859. doi: 10.1093/cid/ciw865.

PMID:
28034886
19.

Real-time qPCR improves meningitis pathogen detection in invasive bacterial-vaccine preventable disease surveillance in Fiji.

Dunne EM, Mantanitobua S, Singh SP, Reyburn R, Tuivaga E, Rafai E, Tikoduadua L, Porter B, Satzke C, Strachan JE, Fox KK, Jenkins KM, Jenney A, Baro S, Mulholland EK, Kama M, Russell FM.

Sci Rep. 2016 Dec 23;6:39784. doi: 10.1038/srep39784.

20.

An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid.

Wong VK, Baker S, Connor TR, Pickard D, Page AJ, Dave J, Murphy N, Holliman R, Sefton A, Millar M, Dyson ZA, Dougan G, Holt KE; International Typhoid Consortium.

Nat Commun. 2016 Oct 5;7:12827. doi: 10.1038/ncomms12827.

21.

Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cells.

Manning J, Dunne EM, Wescombe PA, Hale JD, Mulholland EK, Tagg JR, Robins-Browne RM, Satzke C.

BMC Microbiol. 2016 Sep 29;16(1):225.

22.

Status of research and development of vaccines for Streptococcus pyogenes.

Steer AC, Carapetis JR, Dale JB, Fraser JD, Good MF, Guilherme L, Moreland NJ, Mulholland EK, Schodel F, Smeesters PR.

Vaccine. 2016 Jun 3;34(26):2953-2958. doi: 10.1016/j.vaccine.2016.03.073. Epub 2016 Mar 29.

23.

No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine.

Licciardi PV, Toh ZQ, Clutterbuck EA, Balloch A, Marimla RA, Tikkanen L, Lamb KE, Bright KJ, Rabuatoka U, Tikoduadua L, Boelsen LK, Dunne EM, Satzke C, Cheung YB, Pollard AJ, Russell FM, Mulholland EK.

J Allergy Clin Immunol. 2016 Jun;137(6):1772-1779.e11. doi: 10.1016/j.jaci.2015.12.1303. Epub 2016 Jan 26.

24.

Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents.

La Vincente SF, Mielnik D, Jenkins K, Bingwor F, Volavola L, Marshall H, Druavesi P, Russell FM, Lokuge K, Mulholland EK.

BMC Public Health. 2015 Dec 18;15:1257. doi: 10.1186/s12889-015-2579-3.

25.

The PneuCarriage Project: A Multi-Centre Comparative Study to Identify the Best Serotyping Methods for Examining Pneumococcal Carriage in Vaccine Evaluation Studies.

Satzke C, Dunne EM, Porter BD, Klugman KP, Mulholland EK; PneuCarriage project group.

PLoS Med. 2015 Nov 17;12(11):e1001903; discussion e1001903. doi: 10.1371/journal.pmed.1001903. eCollection 2015 Nov.

26.

PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia.

Binks MJ, Moberley SA, Balloch A, Leach AJ, Nelson S, Hare KM, Wilson C, Morris PS, Nelson J, Chatfield MD, Tang ML, Torzillo P, Carapetis JR, Mulholland EK, Andrews RM.

Vaccine. 2015 Nov 27;33(48):6579-87. doi: 10.1016/j.vaccine.2015.10.101. Epub 2015 Oct 31.

27.

Characterization of 19A-like 19F pneumococcal isolates from Papua New Guinea and Fiji.

Dunne EM, Tikkanen L, Balloch A, Gould K, Yoannes M, Phuanukoonnon S, Licciardi PV, Russell FM, Mulholland EK, Satzke C, Hinds J.

New Microbes New Infect. 2015 Jul 4;7:86-8. doi: 10.1016/j.nmni.2015.06.008. eCollection 2015 Sep.

28.

Reduced dose human papillomavirus vaccination: an update of the current state-of-the-art.

Toh ZQ, Licciardi PV, Fong J, Garland SM, Tabrizi SN, Russell FM, Mulholland EK.

Vaccine. 2015 Sep 22;33(39):5042-50. doi: 10.1016/j.vaccine.2015.07.102. Epub 2015 Aug 10. Review.

PMID:
26271829
29.

Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes.

Boelsen LK, Dunne EM, Lamb KE, Bright K, Cheung YB, Tikoduadua L, Russell FM, Mulholland EK, Licciardi PV, Satzke C.

Vaccine. 2015 Oct 13;33(42):5708-5714. doi: 10.1016/j.vaccine.2015.07.059. Epub 2015 Jul 29.

30.

Reduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children.

Hoe E, Boelsen LK, Toh ZQ, Sun GW, Koo GC, Balloch A, Marimla R, Dunne EM, Tikoduadua L, Russell FM, Satzke C, Mulholland EK, Licciardi PV.

PLoS One. 2015 Jun 12;10(6):e0129199. doi: 10.1371/journal.pone.0129199. eCollection 2015.

31.

Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events.

Wong VK, Baker S, Pickard DJ, Parkhill J, Page AJ, Feasey NA, Kingsley RA, Thomson NR, Keane JA, Weill FX, Edwards DJ, Hawkey J, Harris SR, Mather AE, Cain AK, Hadfield J, Hart PJ, Thieu NT, Klemm EJ, Glinos DA, Breiman RF, Watson CH, Kariuki S, Gordon MA, Heyderman RS, Okoro C, Jacobs J, Lunguya O, Edmunds WJ, Msefula C, Chabalgoity JA, Kama M, Jenkins K, Dutta S, Marks F, Campos J, Thompson C, Obaro S, MacLennan CA, Dolecek C, Keddy KH, Smith AM, Parry CM, Karkey A, Mulholland EK, Campbell JI, Dongol S, Basnyat B, Dufour M, Bandaranayake D, Naseri TT, Singh SP, Hatta M, Newton P, Onsare RS, Isaia L, Dance D, Davong V, Thwaites G, Wijedoru L, Crump JA, De Pinna E, Nair S, Nilles EJ, Thanh DP, Turner P, Soeng S, Valcanis M, Powling J, Dimovski K, Hogg G, Farrar J, Holt KE, Dougan G.

Nat Genet. 2015 Jun;47(6):632-9. doi: 10.1038/ng.3281. Epub 2015 May 11.

32.

Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.

Leach AJ, Mulholland EK, Santosham M, Torzillo PJ, Brown NJ, McIntyre P, Smith-Vaughan H, Skull S, Balloch A, Andrews R, Carapetis J, McDonnell J, Krause V, Morris PS.

BMJ Open. 2015 Jan 16;5(1):e007247. doi: 10.1136/bmjopen-2014-007247.

33.

Early indication for a reduced burden of radiologically confirmed pneumonia in children following the introduction of routine vaccination against Haemophilus influenzae type b in Nha Trang, Vietnam.

Flasche S, Takahashi K, Vu DT, Suzuki M, Nguyen TH, Le H, Hashizume M, Dang DA, Edmond K, Ariyoshi K, Mulholland EK, Edmunds WJ, Yoshida LM.

Vaccine. 2014 Dec 5;32(51):6963-6970. doi: 10.1016/j.vaccine.2014.10.055. Epub 2014 Nov 1.

34.

Impaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage.

Licciardi PV, Russell FM, Balloch A, Burton RL, Nahm MH, Gilbert G, Tang ML, Mulholland EK.

Vaccine. 2014 Apr 25;32(20):2321-7. doi: 10.1016/j.vaccine.2014.02.064. Epub 2014 Mar 6.

35.

Comparison of anti-pneumococcal antibodies in cord blood from Australian indigenous and Gambian neonates and the implications for otitis media.

Balloch A, Licciardi PV, Kemp AS, Leach AJ, Mulholland EK, Tang ML.

Pediatr Infect Dis J. 2014 Apr;33(4):e116-20. doi: 10.1097/INF.0000000000000202.

PMID:
24378950
36.

Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.

O'Grady KA, Grimwood K, Cripps A, Mulholland EK, Morris P, Torzillo PJ, Wood N, Smith-Vaughan H, Revell A, Wilson A, Van Asperen P, Richmond P, Thornton R, Rablin S, Chang AB.

Trials. 2013 Sep 5;14:282. doi: 10.1186/1745-6215-14-282.

37.

Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG.

Wong SS, Quan Toh Z, Dunne EM, Mulholland EK, Tang ML, Robins-Browne RM, Licciardi PV, Satzke C.

BMC Res Notes. 2013 Apr 5;6:135. doi: 10.1186/1756-0500-6-135.

38.

The high burden of cervical cancer in Fiji, 2004-07.

Law I, Fong JJ, Buadromo EM, Samuela J, Patel MS, Garland SM, Mulholland EK, Russell FM.

Sex Health. 2013 May;10(2):171-8. doi: 10.1071/SH12135.

PMID:
23557630
39.

Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination.

Dunne EM, Smith-Vaughan HC, Robins-Browne RM, Mulholland EK, Satzke C.

Vaccine. 2013 May 1;31(19):2333-42. doi: 10.1016/j.vaccine.2013.03.024. Epub 2013 Mar 19. Review.

PMID:
23523773
40.

Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome.

Licciardi PV, Toh ZQ, Dunne E, Wong SS, Mulholland EK, Tang M, Robins-Browne RM, Satzke C.

PLoS Pathog. 2012;8(6):e1002652. doi: 10.1371/journal.ppat.1002652. Epub 2012 Jun 7. No abstract available.

41.

Measles in the 21st century.

Mulholland EK, Griffiths UK, Biellik R.

N Engl J Med. 2012 May 10;366(19):1755-7. doi: 10.1056/NEJMp1202396. No abstract available.

42.

Meningitis in children in Fiji: etiology, epidemiology, and neurological sequelae.

Biaukula VL, Tikoduadua L, Azzopardi K, Seduadua A, Temple B, Richmond P, Robins-Browne R, Mulholland EK, Russell FM.

Int J Infect Dis. 2012 Apr;16(4):e289-95. doi: 10.1016/j.ijid.2011.12.013. Epub 2012 Feb 17.

43.

Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses.

Licciardi PV, Balloch A, Russell FM, Burton RL, Lin J, Nahm MH, Mulholland EK, Tang ML.

J Allergy Clin Immunol. 2012 Mar;129(3):794-800.e2. doi: 10.1016/j.jaci.2011.11.043. Epub 2012 Feb 2.

44.

Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children.

Dunne EM, Manning J, Russell FM, Robins-Browne RM, Mulholland EK, Satzke C.

J Clin Microbiol. 2012 Mar;50(3):1034-8. doi: 10.1128/JCM.06589-11. Epub 2011 Dec 14.

45.

The cost of outpatient pneumonia in children <5 years of age in Fiji.

Temple B, Griffiths UK, Mulholland EK, Ratu FT, Tikoduadua L, Russell FM.

Trop Med Int Health. 2012 Feb;17(2):197-203. doi: 10.1111/j.1365-3156.2011.02897.x. Epub 2011 Oct 18.

46.

Multilocus sequence typing of Streptococcus pneumoniae by use of mass spectrometry.

Dunne EM, Ong EK, Moser RJ, Siba PM, Phuanukoonnon S, Greenhill AR, Robins-Browne RM, Mulholland EK, Satzke C.

J Clin Microbiol. 2011 Nov;49(11):3756-60. doi: 10.1128/JCM.05113-11. Epub 2011 Aug 31. Erratum in: J Clin Microbiol. 2013 Oct;51(10):3471.

47.

Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Fiji.

Tabrizi SN, Law I, Buadromo E, Stevens MP, Fong J, Samuela J, Patel M, Mulholland EK, Russell FM, Garland SM.

Sex Health. 2011 Sep;8(3):338-42. doi: 10.1071/SH10083.

PMID:
21851773
48.

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.

Russell FM, Balloch A, Licciardi PV, Carapetis JR, Tikoduadua L, Waqatakirewa L, Cheung YB, Mulholland EK, Tang ML.

Vaccine. 2011 Jun 15;29(27):4499-506. doi: 10.1016/j.vaccine.2011.04.038. Epub 2011 May 1.

49.

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.

Russell FM, Carapetis JR, Burton RL, Lin J, Licciardi PV, Balloch A, Tikoduadua L, Waqatakirewa L, Cheung YB, Tang ML, Nahm MH, Mulholland EK.

Vaccine. 2011 Jan 10;29(3):535-44. doi: 10.1016/j.vaccine.2010.10.046. Epub 2010 Oct 31.

50.

Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.

Russell FM, Carapetis JR, Satzke C, Tikoduadua L, Waqatakirewa L, Chandra R, Seduadua A, Oftadeh S, Cheung YB, Gilbert GL, Mulholland EK.

Clin Vaccine Immunol. 2010 Dec;17(12):1970-6. doi: 10.1128/CVI.00117-10. Epub 2010 Oct 13.

Supplemental Content

Loading ...
Support Center